Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2009/053626external-prioritypatent/WO2010023594A1/en
Application filed by PfizerfiledCriticalPfizer
Publication of CU20110041A7publicationCriticalpatent/CU20110041A7/en
Publication of CU24003B1publicationCriticalpatent/CU24003B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
En el presente documento se describen compuestos de fórmula (I) y usos de los mismos para el tratamiento de enfermedades, afecciones y/o trastornos mediados por inhibidores del transportador de glucosa dependiente de sodio (en particular, inhibidores de SGLT2). ESPACIO PARA LA FÓRMULACompounds of formula (I) and uses thereof for the treatment of diseases, conditions and / or disorders mediated by sodium-dependent glucose transporter inhibitors (in particular, SGLT2 inhibitors) are described herein. FORMULA SPACE
Heterocycle substituted phenylpiperidine derivative compounds; preparation procedure; pharmaceutical composition comprising it; and use in the treatment of cardiovascular, thromboembolic and tumor disorders; in vitro uses.
Compounds derived from substituted amides, inhibitors of btk activity; pharmaceutical composition comprising them; Useful in the treatment of cancer, bone disorders, autoimmune diseases, among others
3'-n-desmethyl-4 '' - o- (2-diethylaminoetanoyl) -6-o-methyl-9a-aza-9a-homoerythromycin a, its salts and crystalline forms 1, 2 and 3; Preparation process; use to treat inflammatory diseases; pharmaceutical composition; and composition which also comprises another active compound.